BIO-TECHNE CORP

LISTEDNASDAQ

SYMBOLTECH

SIC2836

STATE OF INC.MN

FISCAL YEAR ENDSJune 30

CIK842023

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · LARGE ACCELERATED FILER · 10 FISCAL YEARS OF SEC XBRL DATA, 2017–2026

Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures adjusted for later stock splits (split ratios inferred from EPS restated in later SEC filings).

CAPITALIZATION 6/30/26

($ millions)	Amount	%
Total debt	200	8.7
Stockholders' equity	2,108	91.3
Total capitalization	2,308	100.0

156,818,238 shares outstanding at 17 August 2026 (cover page of the 10-K filed 24 August 2026).

LONG-TERM DEBT 6/30/26

($ millions)	Amount
Long-term debt, noncurrent	200

CAPITAL STOCK 6/30/26

Common shares authorized	400,000,000
Common shares issued	156,095,113
Par or stated value per share ($)	0.01
Outstanding at 8/17/26	156,818,238

DIVIDENDS DECLARED/PAID

Fiscal year	Per share $	Payout %
2026	0.32	27.6
2025	0.32	69.6
2024	0.32	30.5
2023	0.32	18.2
2022	0.32	19.3

HISTORY AND BUSINESS

HISTORY: Incorporated in Minnesota. Formerly known as TECHNE CORP /MN/ (to 28 October 2014).

BUSINESS: Classified by the SEC under Standard Industrial Classification 2836, Biological Products, (No Diagnostic Substances). Large accelerated filer. Principal executive office: 614 Mckinley Place Ne, Minneapolis, MN. Fiscal year ends June 30. For a description of the business, see Item 1 of the latest 10-K.

CONSOLIDATED INCOME ACCOUNT, YEARS ENDED

($ millions)	6/30/26	6/30/25	6/30/24
Revenues	1,215	1,220	1,159
Cost of revenues	416	429	389
Gross profit	799	790	770
Research and development	95	99	97
Selling, general and administrative	452	589	466
Depreciation and amortization	97	110	112
Operating income	252	102	207
Interest expense	10	9	16
Income before income taxes	241	98	186
Income taxes	59	25	18
Net income	182	73	168
Earned per share, diluted ($)	1.16	0.46	1.05
Dividends per share ($)	0.32	0.32	0.32

CONSOLIDATED BALANCE SHEET

($ millions)	6/30/26	6/30/25
Cash and equivalents	265	162
Receivables, net	217	207
Inventories	196	189
Total current assets	744	608
Property, plant and equipment, net	232	246
Goodwill	975	981
Total assets	2,587	2,558
Total current liabilities	164	176
Long-term debt	200	346
Stockholders' equity	2,108	1,919
Total liabilities and equity	2,587	2,558

TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)

Fiscal year ended	Revenues	Oper. income	Net income	Net margin %	EPS diluted $	Div. per share $	Oper. cash flow	Capital expend.	Free cash flow	Total assets	Total liabilities	Total debt	Stockholders' equity	ROE %	Debt / equity
6/30/26	1,215	252	182	15.0	1.16	0.32	292	29	263	2,587	479d	200	2,108	8.6	0.09
6/30/25	1,220	102	73	6.0	0.46	0.32	288	31	257	2,558	639d	346	1,919	3.8	0.18
6/30/24	1,159	207	168	14.5	1.05	0.32	299	63	236	2,704	635d	319	2,069	8.1	0.15
6/30/23	1,137	299	285	25.1	1.76	0.32	254	38	216	2,639	672d	350	1,967	14.5	0.18
6/30/22	1,106	297	272	24.6	1.66	0.32	325	45	280	2,295	594d	256	1,702	16.0	0.15
6/30/21	931	237	140	15.1	0.87	0.32	352	44	308	2,263	692d	341	1,563	9.0	0.22
6/30/20	739	157	229	31.0	1.46	0.32	205	52	153	2,028	646d	357	1,381	16.6	0.26
6/30/19	714	147	96	13.5	0.62	0.32	182	25	156	1,884	719d	505	1,166	8.2	0.43
6/30/18	643	136	126	19.6	0.83	0.32	170	21	149	1,593	514d	339	1,079	11.7	0.31
6/30/17	563	121	76	13.5	0.51	0.32	144	15	129	1,558	609d	344	950	8.0	0.36

Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.

REGISTRANT:

BIO-TECHNE Corp
CIK 842023 · EIN 41-1427402

PRINCIPAL OFFICE:

614 Mckinley Place Ne, Minneapolis, MN
Tel.: 612-379-8854

INCORPORATED:

Minnesota

INDUSTRY (SEC SIC CODE):

2836 · Biological Products, (No Diagnostic Substances)

FILER STATUS:

Large accelerated filer

LATEST ANNUAL REPORT:

10-K for period ended 6/30/26, filed 24 August 2026

FORMER NAMES:

TECHNE CORP /MN/

RECENT FILINGS (ANNUAL REPORT REFERENCES BELOW):

9/23/26	8-K	period 9/23/26
9/14/26	8-K	period 9/14/26
8/24/26	10-K	period 6/30/26
8/12/26	8-K	period 8/12/26
6/26/26	8-K	period 6/23/26
6/25/26	8-K	period 6/25/26
5/6/26	10-Q	period 3/31/26
5/6/26	8-K	period 5/6/26

Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2026 (filed 8/24/26) · 10-K FY2025 (filed 8/22/25) · 10-K FY2024 (filed 8/22/24) · 10-K FY2023 (filed 8/23/23) · 10-K FY2022 (filed 8/24/22) · 10-K FY2021 (filed 8/25/21) · 10-K FY2020 (filed 8/26/20) · 10-K/A FY2019 (filed 11/6/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.